{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T23:00:36Z","timestamp":1795129236013,"version":"4.10.3"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T00:00:00Z","timestamp":1503964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T00:00:00Z","timestamp":1503964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nephrotic syndrome is a common disorder in adults and children whose etiology is largely unknown. Glucocorticoids remain the mainstay of therapy in most cases, though their mechanism of action remains poorly understood. Emerging evidence suggests that immunomodulatory therapies used in nephrotic syndrome directly target the podocytes. To study how steroids directly affect the podocytes in the treatment of proteinuria, we created a mouse model with podocyte-specific deletion of the glucocorticoid receptor. The podocyte-specific glucocorticoid receptor (GR) knockout mice had similar renal function and protein excretion compared to wild type. However, after glomerular injury induced by either LPS or nephrotoxic serum, the podocyte GR knockout mice demonstrated worsened proteinuria compared to wild type. Ultrastructural examination of podocytes confirmed more robust foot process effacement in the knockout animals. Expression of several key slit diaphragm protein was down regulated in pGR KO mice. Primary podocytes isolated from wild type and podocyte GR knockout mice showed similar actin stress fiber staining patterns in unstimulated conditions. Yet, when exposed to LPS, GR knockout podocytes demonstrated fewer stress fibers and impaired migration compared to wild type podocytes. We conclude that the podocyte glucocorticoid receptor is important for limiting proteinuria in settings of podocyte injury.<\/jats:p>","DOI":"10.1038\/s41598-017-10490-z","type":"journal-article","created":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T11:35:45Z","timestamp":1503488145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Loss of the podocyte glucocorticoid receptor exacerbates proteinuria after injury"],"prefix":"10.1038","volume":"7","author":[{"given":"Han","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alda","family":"Tufro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Moeckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuta","family":"Ishibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,29]]},"reference":[{"key":"10490_CR1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S0272-6386(99)70384-7","volume":"34","author":"C Ponticelli","year":"1999","unstructured":"Ponticelli, C. et al. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis \n                           34, 618\u2013625 (1999).","journal-title":"Am J Kidney Dis"},{"key":"10490_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1440-1754.2007.01077.x","volume":"43","author":"W Wong","year":"2007","unstructured":"Wong, W. Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study. J Paediatr Child Health \n                           43, 337\u2013341 (2007).","journal-title":"J Paediatr Child Health"},{"key":"10490_CR3","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1681\/ASN.V85824","volume":"8","author":"BM Tune","year":"1997","unstructured":"Tune, B. M. & Mendoza, S. A. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults. J Am Soc Nephrol \n                           8, 824\u2013832 (1997).","journal-title":"J Am Soc Nephrol"},{"key":"10490_CR4","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00467-008-0792-3","volume":"23","author":"EM Hodson","year":"2008","unstructured":"Hodson, E. M. & Craig, J. C. Therapies for steroid-resistant nephrotic syndrome. Pediatr Nephrol \n                           23, 1391\u20131394 (2008).","journal-title":"Pediatr Nephrol"},{"key":"10490_CR5","doi-asserted-by":"publisher","first-page":"S163","DOI":"10.1590\/S0021-75572007000700007","volume":"83","author":"CA Longui","year":"2007","unstructured":"Longui, C. A. Glucocorticoid therapy: minimizing side effects. J Pediatr (Rio J) \n                           83, S163\u2013177 (2007).","journal-title":"J Pediatr (Rio J)"},{"key":"10490_CR6","first-page":"713","volume":"136","author":"P Fodor","year":"1982","unstructured":"Fodor, P., Saitua, M. T., Rodriguez, E., Gonzalez, B. & Schlesinger, L. T-cell dysfunction in minimal-change nephrotic syndrome of childhood. Am J Dis Child \n                           136, 713\u2013717 (1982).","journal-title":"Am J Dis Child"},{"key":"10490_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000181756","volume":"25","author":"M Sasdelli","year":"1980","unstructured":"Sasdelli, M. et al. Lymphocyte subpopulations in minimal-change nephropathy. Nephron \n                           25, 72\u201376 (1980).","journal-title":"Nephron"},{"key":"10490_CR8","first-page":"294","volume":"1","author":"YM Wang","year":"2008","unstructured":"Wang, Y. M. et al. Regulatory T cells in renal disease. International journal of clinical and experimental medicine \n                           1, 294\u2013304 (2008).","journal-title":"International journal of clinical and experimental medicine"},{"key":"10490_CR9","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1681\/ASN.2006060622","volume":"18","author":"H Wu","year":"2007","unstructured":"Wu, H. et al. Depletion of gammadelta T cells exacerbates murine adriamycin nephropathy. J Am Soc Nephrol \n                           18, 1180\u20131189 (2007).","journal-title":"J Am Soc Nephrol"},{"key":"10490_CR10","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10157-011-0465-6","volume":"15","author":"T Takei","year":"2011","unstructured":"Takei, T. & Nitta, K. Rituximab and minimal change nephrotic syndrome: a therapeutic option. Clinical and experimental nephrology \n                           15, 641\u2013647 (2011).","journal-title":"Clinical and experimental nephrology"},{"key":"10490_CR11","first-page":"719","volume":"135","author":"AA Eddy","year":"1989","unstructured":"Eddy, A. A. Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol \n                           135, 719\u2013733 (1989).","journal-title":"Am J Pathol"},{"key":"10490_CR12","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.4049\/jimmunol.177.6.4094","volume":"177","author":"D Turnberg","year":"2006","unstructured":"Turnberg, D. et al. Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice. J Immunol \n                           177, 4094\u20134102 (2006).","journal-title":"J Immunol"},{"key":"10490_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032454","volume":"7","author":"RL Pereira","year":"2012","unstructured":"Pereira, R. L. et al. Invariant natural killer T cell agonist modulates experimental focal and segmental glomerulosclerosis. PloS one \n                           7, e32454 (2012).","journal-title":"PloS one"},{"key":"10490_CR14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.4049\/jimmunol.172.1.688","volume":"172","author":"A Valanciute","year":"2004","unstructured":"Valanciute, A. et al. NF-kappa B p65 antagonizes IL-4 induction by c-maf in minimal change nephrotic syndrome. J Immunol \n                           172, 688\u2013698 (2004).","journal-title":"J Immunol"},{"key":"10490_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev.pathol.1.110304.100119","volume":"1","author":"C Kwoh","year":"2006","unstructured":"Kwoh, C., Shannon, M. B., Miner, J. H. & Shaw, A. Pathogenesis of nonimmune glomerulopathies. Annu Rev Pathol \n                           1, 349\u2013374 (2006).","journal-title":"Annu Rev Pathol"},{"key":"10490_CR16","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1159\/000101793","volume":"106","author":"CB Marshall","year":"2007","unstructured":"Marshall, C. B. & Shankland, S. J. Cell cycle regulatory proteins in podocyte health and disease. Nephron Exp Nephrol \n                           106, e51\u201359 (2007).","journal-title":"Nephron Exp Nephrol"},{"key":"10490_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"2","author":"RJ Shalhoub","year":"1974","unstructured":"Shalhoub, R. J. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet \n                           2, 556\u2013560 (1974).","journal-title":"Lancet"},{"key":"10490_CR18","doi-asserted-by":"crossref","unstructured":"Schonenberger, E., Ehrich, J. H., Haller, H. & Schiffer, M. The podocyte as a direct target of immunosuppressive agents. Nephrol Dial Transplant \n                           26, 18\u201324.","DOI":"10.1093\/ndt\/gfq617"},{"key":"10490_CR19","doi-asserted-by":"crossref","unstructured":"Guess, A. et al. Dose- and time-dependent glucocorticoid receptor signaling in podocytes. Am J Physiol Renal Physiol \n                           299, F845\u2013853.","DOI":"10.1152\/ajprenal.00161.2010"},{"key":"10490_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1046\/j.1523-1755.1999.00503.x","volume":"56","author":"K Yan","year":"1999","unstructured":"Yan, K. et al. Subcellular localization of glucocorticoid receptor protein in the human kidney glomerulus. Kidney Int \n                           56, 65\u201373 (1999).","journal-title":"Kidney Int"},{"key":"10490_CR21","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1111\/j.1523-1755.2005.00723.x","volume":"68","author":"RF Ransom","year":"2005","unstructured":"Ransom, R. F., Lam, N. G., Hallett, M. A., Atkinson, S. J. & Smoyer, W. E. Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int \n                           68, 2473\u20132483 (2005).","journal-title":"Kidney Int"},{"key":"10490_CR22","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1681\/ASN.2005020142","volume":"16","author":"T Wada","year":"2005","unstructured":"Wada, T., Pippin, J. W., Marshall, C. B., Griffin, S. V. & Shankland, S. J. Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins. J Am Soc Nephrol \n                           16, 2615\u20132625 (2005).","journal-title":"J Am Soc Nephrol"},{"key":"10490_CR23","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1681\/ASN.2007080911","volume":"19","author":"JE Goodwin","year":"2008","unstructured":"Goodwin, J. E., Zhang, J. & Geller, D. S. A critical role for vascular smooth muscle in acute glucocorticoid-induced hypertension. J Am Soc Nephrol \n                           19, 1291\u20131299 (2008).","journal-title":"J Am Soc Nephrol"},{"key":"10490_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/gene.10164","volume":"35","author":"MJ Moeller","year":"2003","unstructured":"Moeller, M. J., Sanden, S. K., Soofi, A., Wiggins, R. C. & Holzman, L. B. Podocyte-specific expression of cre recombinase in transgenic mice. Genesis \n                           35, 39\u201342 (2003).","journal-title":"Genesis"},{"key":"10490_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111285","volume":"9","author":"R Bertelli","year":"2014","unstructured":"Bertelli, R. et al. LPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activity. PloS one \n                           9, e111285 (2014).","journal-title":"PloS one"},{"key":"10490_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-1-4939-0882-0_15","volume":"1169","author":"JM Hoppe","year":"2014","unstructured":"Hoppe, J. M. & Vielhauer, V. Induction and analysis of nephrotoxic serum nephritis in mice. Methods in molecular biology \n                           1169, 159\u2013174 (2014).","journal-title":"Methods in molecular biology"},{"key":"10490_CR27","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1681\/ASN.2009090991","volume":"21","author":"H Ma","year":"2010","unstructured":"Ma, H. et al. Inhibition of podocyte FAK protects against proteinuria and foot process effacement. J Am Soc Nephrol \n                           21, 1145\u20131156 (2010).","journal-title":"J Am Soc Nephrol"},{"key":"10490_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-physiol-020911-153238","volume":"74","author":"A Greka","year":"2012","unstructured":"Greka, A. & Mundel, P. Cell biology and pathology of podocytes. Annu Rev Physiol \n                           74, 299\u2013323 (2012).","journal-title":"Annu Rev Physiol"},{"key":"10490_CR29","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1172\/JCI69778","volume":"124","author":"X Tian","year":"2014","unstructured":"Tian, X. et al. Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance. J Clin Invest \n                           124, 1098\u20131113 (2014).","journal-title":"J Clin Invest"},{"key":"10490_CR30","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.3892\/mmr.2015.4370","volume":"12","author":"M Ye","year":"2015","unstructured":"Ye, M. et al. Prednisone inhibits the focal adhesion kinase\/receptor activator of NF-kappaB ligand\/mitogen-activated protein kinase signaling pathway in rats with adriamycin-induced nephropathy. Mol Med Rep \n                           12, 7471\u20137478 (2015).","journal-title":"Mol Med Rep"},{"key":"10490_CR31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1073\/pnas.1210200110","volume":"110","author":"JE Goodwin","year":"2013","unstructured":"Goodwin, J. E., Feng, Y., Velazquez, H. & Sessa, W. C. Endothelial glucocorticoid receptor is required for protection against sepsis. Proc Natl Acad Sci USA \n                           110, 306\u2013311 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"10490_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1165\/rcmb.2009-0263OC","volume":"43","author":"N Manwani","year":"2010","unstructured":"Manwani, N. et al. Reduced viability of mice with lung epithelial-specific knockout of glucocorticoid receptor. Am J Respir Cell Mol Biol \n                           43, 599\u2013606 (2010).","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10490_CR33","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/383726a0","volume":"383","author":"E Stocklin","year":"1996","unstructured":"Stocklin, E., Wissler, M., Gouilleux, F. & Groner, B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature \n                           383, 726\u2013728 (1996).","journal-title":"Nature"},{"key":"10490_CR34","first-page":"388","volume":"24","author":"P Mundel","year":"2015","unstructured":"Mundel, P. & Greka, A. Developing therapeutic \u2018arrows\u2019 with the precision of William Tell: the time has come for targeted therapies in kidney disease. Curr Opin Nephrol Hypertens \n                           24, 388\u2013392 (2015).","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10490_CR35","doi-asserted-by":"publisher","first-page":"F554","DOI":"10.1152\/ajprenal.00391.2007","volume":"294","author":"SA Asgeirsdottir","year":"2008","unstructured":"Asgeirsdottir, S. A. et al. Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes. Am J Physiol Renal Physiol \n                           294, F554\u2013561 (2008).","journal-title":"Am J Physiol Renal Physiol"},{"key":"10490_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1124\/mol.107.034140","volume":"72","author":"SA Asgeirsdottir","year":"2007","unstructured":"Asgeirsdottir, S. A. et al. Site-specific inhibition of glomerulonephritis progression by targeted delivery of dexamethasone to glomerular endothelium. Molecular pharmacology \n                           72, 121\u2013131 (2007).","journal-title":"Molecular pharmacology"},{"key":"10490_CR37","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s11095-006-9213-0","volume":"24","author":"K Morimoto","year":"2007","unstructured":"Morimoto, K. et al. Advances in targeting drug delivery to glomerular mesangial cells by long circulating cationic liposomes for the treatment of glomerulonephritis. Pharmaceutical research \n                           24, 946\u2013954 (2007).","journal-title":"Pharmaceutical research"},{"key":"10490_CR38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jconrel.2013.02.001","volume":"167","author":"Y Lin","year":"2013","unstructured":"Lin, Y. et al. Targeted drug delivery to renal proximal tubule epithelial cells mediated by 2-glucosamine. Journal of controlled release: official journal of the Controlled Release Society \n                           167, 148\u2013156 (2013).","journal-title":"Journal of controlled release: official journal of the Controlled Release Society"},{"key":"10490_CR39","volume":"2013","author":"S Yu","year":"2013","unstructured":"Yu, S. & Li, Y. Dexamethasone inhibits podocyte apoptosis by stabilizing the PI3K\/Akt signal pathway. BioMed research international \n                           2013, 326986 (2013).","journal-title":"BioMed research international"},{"key":"10490_CR40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1440-1797.2012.01645.x","volume":"17","author":"H Liu","year":"2012","unstructured":"Liu, H. et al. alpha-Actinin-4 is involved in the process by which dexamethasone protects actin cytoskeleton stabilization from adriamycin-induced podocyte injury. Nephrology (Carlton) \n                           17, 669\u2013675 (2012).","journal-title":"Nephrology (Carlton)"},{"key":"10490_CR41","doi-asserted-by":"publisher","first-page":"8173","DOI":"10.1074\/jbc.M708920200","volume":"283","author":"TC Lu","year":"2008","unstructured":"Lu, T. C. et al. HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein. J Biol Chem \n                           283, 8173\u20138182 (2008).","journal-title":"J Biol Chem"},{"key":"10490_CR42","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1074\/jbc.M116.755546","volume":"292","author":"X Zhao","year":"2017","unstructured":"Zhao, X. et al. alpha Actinin 4 (ACTN4) Regulates Glucocorticoid Receptor-mediated Transactivation and Transrepression in Podocytes. J Biol Chem \n                           292, 1637\u20131647 (2017).","journal-title":"J Biol Chem"},{"key":"10490_CR43","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/ncb1400","volume":"8","author":"K Asanuma","year":"2006","unstructured":"Asanuma, K. et al. Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling. Nat Cell Biol \n                           8, 485\u2013491 (2006).","journal-title":"Nat Cell Biol"},{"key":"10490_CR44","doi-asserted-by":"publisher","first-page":"p9","DOI":"10.1159\/000191075","volume":"111","author":"PY Chuang","year":"2009","unstructured":"Chuang, P. Y. & He, J. C. Signaling in regulation of podocyte phenotypes. Nephron Physiol \n                           111, p9\u201315 (2009).","journal-title":"Nephron Physiol"},{"key":"10490_CR45","doi-asserted-by":"publisher","first-page":"34827","DOI":"10.1074\/jbc.M401973200","volume":"279","author":"J Reiser","year":"2004","unstructured":"Reiser, J. et al. Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin. J Biol Chem \n                           279, 34827\u201334832 (2004).","journal-title":"J Biol Chem"},{"key":"10490_CR46","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1681\/ASN.2015060672","volume":"28","author":"SK Mallipattu","year":"2017","unstructured":"Mallipattu, S. K. et al. Kruppel-Like Factor 15 Mediates Glucocorticoid-Induced Restoration of Podocyte Differentiation Markers. J Am Soc Nephrol \n                           28, 166\u2013184 (2017).","journal-title":"J Am Soc Nephrol"},{"key":"10490_CR47","doi-asserted-by":"publisher","first-page":"F213","DOI":"10.1152\/ajprenal.90421.2008","volume":"296","author":"JW Pippin","year":"2009","unstructured":"Pippin, J. W. et al. Inducible rodent models of acquired podocyte diseases. Am J Physiol Renal Physiol \n                           296, F213\u2013229 (2009).","journal-title":"Am J Physiol Renal Physiol"},{"key":"10490_CR48","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1046\/j.1523-1755.1998.00003.x","volume":"54","author":"V Ophascharoensuk","year":"1998","unstructured":"Ophascharoensuk, V. et al. Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation. Kidney Int \n                           54, 416\u2013425 (1998).","journal-title":"Kidney Int"},{"key":"10490_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/srep24392","volume":"6","author":"S Agrawal","year":"2016","unstructured":"Agrawal, S. et al. Pioglitazone Enhances the Beneficial Effects of Glucocorticoids in Experimental Nephrotic Syndrome. Scientific reports \n                           6, 24392 (2016).","journal-title":"Scientific reports"},{"key":"10490_CR50","doi-asserted-by":"crossref","unstructured":"Kuppe, C. et al. Investigations of Glucocorticoid Action in GN. J Am Soc Nephrol (2016).","DOI":"10.1681\/ASN.2016010060"},{"key":"10490_CR51","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.ajpath.2014.05.005","volume":"184","author":"T Kumagai","year":"2014","unstructured":"Kumagai, T. et al. Protein tyrosine phosphatase 1B inhibition protects against podocyte injury and proteinuria. Am J Pathol \n                           184, 2211\u20132224 (2014).","journal-title":"Am J Pathol"},{"key":"10490_CR52","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0022-2143(99)90123-3","volume":"134","author":"SB Koukouritaki","year":"1999","unstructured":"Koukouritaki, S. B., Tamizuddin, A. & Lianos, E. A. Enhanced expression of the cytoskeleton-associated proteins paxillin and focal adhesion kinase in glomerular immune injury. J Lab Clin Med \n                           134, 173\u2013179 (1999).","journal-title":"J Lab Clin Med"},{"key":"10490_CR53","first-page":"1149","volume":"34","author":"X Chen","year":"2014","unstructured":"Chen, X. et al. Effects of prednisone on renal FAK and Pyk2 expressions in rats with adriamycin- induced nephritis. Nan Fang Yi Ke Da Xue Xue Bao \n                           34, 1149\u20131153 (2014).","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10490_CR54","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/jcp.22383","volume":"226","author":"SP Yun","year":"2011","unstructured":"Yun, S. P., Ryu, J. M. & Han, H. J. Involvement of beta1-integrin via PIP complex and FAK\/paxillin in dexamethasone-induced human mesenchymal stem cells migration. J Cell Physiol \n                           226, 683\u2013692 (2011).","journal-title":"J Cell Physiol"},{"key":"10490_CR55","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/01.brs.0000250997.24617.a4","volume":"32","author":"BK Jee","year":"2007","unstructured":"Jee, B. K. et al. Role of tumor necrosis factor-alpha, interleukin-8, and dexamethasone in the focal adhesion kinase expression by human nucleus pulposus cells. Spine (Phila Pa 1976) \n                           32, 30\u201335 (2007).","journal-title":"Spine (Phila Pa 1976)"},{"key":"10490_CR56","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/BF03402097","volume":"5","author":"SB Koukouritaki","year":"1999","unstructured":"Koukouritaki, S. B., Gravanis, A. & Stournaras, C. Tyrosine phosphorylation of focal adhesion kinase and paxillin regulates the signaling mechanism of the rapid nongenomic action of dexamethasone on actin cytoskeleton. Mol Med \n                           5, 731\u2013742 (1999).","journal-title":"Mol Med"},{"key":"10490_CR57","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/HJH.0b013e328347da54","volume":"29","author":"JE Goodwin","year":"2011","unstructured":"Goodwin, J. E., Zhang, J., Gonzalez, D., Albinsson, S. & Geller, D. S. Knockout of the vascular endothelial glucocorticoid receptor abrogates dexamethasone-induced hypertension. J Hypertens \n                           29, 1347\u20131356 (2011).","journal-title":"J Hypertens"},{"key":"10490_CR58","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1172\/JCI200523371","volume":"115","author":"K Asanuma","year":"2005","unstructured":"Asanuma, K. et al. Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. J Clin Invest \n                           115, 1188\u20131198 (2005).","journal-title":"J Clin Invest"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10490-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10490-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10490-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T09:50:31Z","timestamp":1671789031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10490-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,29]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["10490"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-10490-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,29]]},"assertion":[{"value":"3 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9833"}}